🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and efficacy of avatrombopag in subject...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-14
Trial ID
NCT05046327
Treatments Being Tested
This study will be a single-center, open-label, randomized, 3-treatment cro...
Status
Completed
Location
Celerion
Start Date
2010-01
Trial ID
NCT01260155
Evaluate the efficacy, safety, and PK of avatrombopag given for 26 weeks in...
Status
Completed
Location
Sobi Site 105
Start Date
2022-06-15
Trial ID
NCT05369208
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of AKR-50...
Status
Completed
Location
Pacific Cancer Medical Center, Inc
Start Date
2007-05
Trial ID
NCT00625443
Treatments Being Tested
A Randomized, Open-label, Three-period, Partial-replicate Design Study to E...
Status
Completed
Location
Celerion
Start Date
2012-10
Trial ID
NCT01759394
Treatments Being Tested
Evaluate the safety and tolerability of avatrombopag given for 90 days afte...
Status
Completed
Location
Sobi Site 110
Start Date
2021-03-15
Trial ID
NCT04638829
Treatments Being Tested
Phase 3 randomized, double-blind, placebo-controlled study to evaluate the ...
Status
Completed
Location
Dova Site
Start Date
2018-10-12
Trial ID
NCT03471078
Treatments Being Tested
This research study is testing a medicine called avatrombopag in adults wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-31
Trial ID
NCT07786922
Treatments Being Tested
This study is a phase 3 study where eligible patients will be randomized 1:...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-15
Trial ID
NCT07051915
Treatments Being Tested
A Phase 3b Study to Evaluate the Efficacy and Safety of Avatrombopag for th...
Status
Completed
Location
Site 112
Start Date
2021-03-05
Trial ID
NCT04516967
Treatments Being Tested